ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
NewcelX Ltd.
3.26
-0.1073
-3.18%
盤後:
3.26
0.0000
0.00%
19:30 EDT
成交量:
1,395
成交額:
4,580.00
市值:
1,743.98萬
市盈率:
-1.51
高:
3.31
開:
3.31
低:
3.22
收:
3.37
52周最高:
28.03
52周最低:
1.83
股本:
534.52萬
流通股本:
273.89萬
量比:
0.08
換手率:
0.05%
股息:
- -
股息率:
- -
每股收益(TTM):
-2.1600
每股收益(LYR):
-2.1592
淨資產收益率:
--
總資產收益率:
-25.94%
市淨率:
2.41
市盈率(LYR):
-1.51
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
NewcelX任命世界知名糖尿病治療先驅Camillo Ricordi博士加入科學顧問委員會
美股速递
·
07/08
Newcelx宣佈FDA臨床前會議成功,為Ncel-101啓動1型糖尿病臨床試驗鋪平道路
美股速递
·
07/01
NewcelX公布2025財年業績 攜手Eledon製藥加速推進2026年1型糖尿病療法研發進程
美股速递
·
04/30
Newcelx更新企業演示文稿,重點展示與Eledon製藥戰略合作後的1型糖尿病旗艦項目,瑞士生物技術會議前揭曉
美股速递
·
04/20
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/NCEL"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NCEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCEL\",,,,,undefined,":{"symbol":"NCEL","market":"US","secType":"STK","nameCN":"NewcelX Ltd.","latestPrice":3.2627,"timestamp":1787342400000,"preClose":3.37,"halted":0,"volume":1395,"hourTrading":{"tag":"盘后","latestPrice":3.2627,"preClose":3.2627,"latestTime":"19:30 EDT","volume":8,"amount":26.88,"timestamp":1787355006084,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.03183976261127595,"floatShares":2738900,"shares":5345200,"eps":-2.159999,"marketStatus":"休市中","change":-0.1073,"latestTime":"08-21 16:00:00 EDT","open":3.31,"high":3.31,"low":3.2153,"amount":4579.99983,"amplitude":0.028101,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.159999,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":3.37,"preHourTrading":{"tag":"盘前","latestPrice":3.37,"preClose":3.37,"latestTime":"08:51 EDT","volume":35,"amount":117.95,"timestamp":1787316695357,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":3.2627,"preClose":3.2627,"latestTime":"19:30 EDT","volume":8,"amount":26.88,"timestamp":1787355006084,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.08353693500067978},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCEL\",,,,,undefined,":{"symbol":"NCEL","floatShares":2738900,"roa":"-25.94%","roe":"--","lyrEps":-2.159218,"volumeRatio":0.08353693500067978,"shares":5345200,"dividePrice":0,"high":3.31,"amplitude":0.028101,"preClose":3.37,"low":3.2153,"week52Low":1.8299,"pbRate":"2.41","week52High":28.032,"institutionHeld":0,"latestPrice":3.2627,"eps":-2.159999,"divideRate":0,"volume":1395,"delay":0,"ttmEps":-2.159999,"open":3.31,"prevYearClose":1.9,"prevWeekClose":3.345,"prevMonthClose":3.49,"prevQuarterClose":3.66,"fiveDayClose":3.345,"twentyDayClose":3.755,"sixtyDayClose":3.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NCEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-30","symbol":"NCEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-10-31","symbol":"NCEL","defaultRemindTime":1761917400000,"type":"split","dateTimestamp":1761883200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-05-16","symbol":"NCEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747368000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-09-27","symbol":"NCEL","defaultRemindTime":1727443800000,"type":"split","dateTimestamp":1727409600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NCEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NCEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1784001600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NCEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NCEL","date":"2026-08-21","current":-1.51051,"percent":0.18593,"low":-2.743828,"twenty":-2.167171,"median":-0.833563,"eighty":-0.589629,"high":-0.434312,"avg":-1.267621,"sd":0.777563,"marketCap":18143645},"quantilePoints":[{"date":"2025-10-31","current":-2.085416,"twenty":-2.085416,"median":-2.085416,"eighty":-2.085416,"marketCap":39937082.48},{"date":"2025-11-07","current":-0.993097,"twenty":-1.495376,"median":-1.229626,"eighty":-1.098389,"marketCap":18917268},{"date":"2025-11-14","current":-0.808829,"twenty":-1.253274,"median":-0.970727,"eighty":-0.876223,"marketCap":15635236},{"date":"2025-11-21","current":-0.750891,"twenty":-1.145695,"median":-0.878334,"eighty":-0.814355,"marketCap":14358890},{"date":"2025-11-28","current":-0.957951,"twenty":-1.045743,"median":-0.867781,"eighty":-0.806793,"marketCap":18279095},{"date":"2025-12-05","current":-0.856292,"twenty":-0.972009,"median":-0.871696,"eighty":-0.812974,"marketCap":16455744},{"date":"2025-12-12","current":-0.781666,"twenty":-0.995845,"median":-0.875612,"eighty":-0.812974,"marketCap":15179398},{"date":"2025-12-19","current":-0.635834,"twenty":-0.972009,"median":-0.85736,"eighty":-0.781019,"marketCap":12353204},{"date":"2025-12-26","current":-0.613233,"twenty":-0.957493,"median":-0.83848,"eighty":-0.693066,"marketCap":11988534},{"date":"2026-01-02","current":-0.442896,"twenty":-0.955117,"median":-0.833152,"eighty":-0.615876,"marketCap":8660918},{"date":"2026-01-09","current":-0.513637,"twenty":-0.941907,"median":-0.808829,"eighty":-0.589968,"marketCap":10074015},{"date":"2026-01-16","current":-0.561129,"twenty":-0.915578,"median":-0.78535,"eighty":-0.566624,"marketCap":11122442},{"date":"2026-01-23","current":-0.610165,"twenty":-0.913462,"median":-0.76547,"eighty":-0.561129,"marketCap":12125285},{"date":"2026-01-30","current":-0.576613,"twenty":-0.882218,"median":-0.6841,"eighty":-0.565731,"marketCap":11623863},{"date":"2026-02-06","current":-0.601541,"twenty":-0.878334,"median":-0.628521,"eighty":-0.570197,"marketCap":12034117},{"date":"2026-02-13","current":-0.627168,"twenty":-0.875612,"median":-0.627168,"eighty":-0.572325,"marketCap":12717874},{"date":"2026-02-20","current":-0.632256,"twenty":-0.869347,"median":-0.627168,"eighty":-0.573006,"marketCap":12581123},{"date":"2026-02-27","current":-0.656951,"twenty":-0.860299,"median":-0.626808,"eighty":-0.575926,"marketCap":13082544},{"date":"2026-03-06","current":-0.638142,"twenty":-0.856719,"median":-0.630594,"eighty":-0.581513,"marketCap":12854625},{"date":"2026-03-13","current":-0.639458,"twenty":-0.843011,"median":-0.628376,"eighty":-0.587749,"marketCap":12717874},{"date":"2026-03-20","current":-0.559522,"twenty":-0.837754,"median":-0.626853,"eighty":-0.587749,"marketCap":11168026},{"date":"2026-03-27","current":-0.565498,"twenty":-0.835865,"median":-0.623182,"eighty":-0.571899,"marketCap":11259193},{"date":"2026-04-02","current":-0.537802,"twenty":-0.83268,"median":-0.620613,"eighty":-0.56375,"marketCap":10712188},{"date":"2026-04-10","current":-0.468376,"twenty":-0.821759,"median":-0.618412,"eighty":-0.555851,"marketCap":9527010},{"date":"2026-04-17","current":-0.546102,"twenty":-0.811592,"median":-0.616697,"eighty":-0.55169,"marketCap":11350361},{"date":"2026-04-24","current":-1.072253,"twenty":-0.811592,"median":-0.617492,"eighty":-0.552903,"marketCap":22381635},{"date":"2026-05-01","current":-0.95322,"twenty":-0.83268,"median":-0.620255,"eighty":-0.55452,"marketCap":20102446},{"date":"2026-05-08","current":-1.779415,"twenty":-0.838489,"median":-0.62112,"eighty":-0.555851,"marketCap":14769144},{"date":"2026-05-15","current":-2.224901,"twenty":-0.870913,"median":-0.625846,"eighty":-0.556353,"marketCap":18466677},{"date":"2026-05-22","current":-2.062736,"twenty":-0.91452,"median":-0.627168,"eighty":-0.558257,"marketCap":17120709},{"date":"2026-05-29","current":-2.296253,"twenty":-0.955372,"median":-0.628812,"eighty":-0.55988,"marketCap":19058903},{"date":"2026-06-05","current":-2.043276,"twenty":-1.009476,"median":-0.634045,"eighty":-0.560702,"marketCap":16959193},{"date":"2026-06-12","current":-2.118586,"twenty":-1.18766,"median":-0.639458,"eighty":-0.562877,"marketCap":17584261},{"date":"2026-06-18","current":-2.043276,"twenty":-1.814564,"median":-0.642142,"eighty":-0.565545,"marketCap":16959193},{"date":"2026-06-26","current":-2.30274,"twenty":-1.957423,"median":-0.652667,"eighty":-0.566624,"marketCap":19112742},{"date":"2026-07-02","current":-2.497338,"twenty":-2.043276,"median":-0.658096,"eighty":-0.570197,"marketCap":20727903},{"date":"2026-07-10","current":-2.678962,"twenty":-2.05625,"median":-0.697542,"eighty":-0.572325,"marketCap":22235387},{"date":"2026-07-17","current":-2.536257,"twenty":-2.075709,"median":-0.73457,"eighty":-0.573176,"marketCap":21050935},{"date":"2026-07-24","current":-2.464905,"twenty":-2.085416,"median":-0.750891,"eighty":-0.576613,"marketCap":20458709},{"date":"2026-07-31","current":-2.180403,"twenty":-2.102953,"median":-0.781666,"eighty":-0.580006,"marketCap":18097343},{"date":"2026-08-07","current":-2.166522,"twenty":-2.154845,"median":-0.801508,"eighty":-0.582361,"marketCap":17982129},{"date":"2026-08-14","current":-2.335173,"twenty":-2.160035,"median":-0.815737,"eighty":-0.587749,"marketCap":19381935},{"date":"2026-08-21","current":-2.185981,"twenty":-2.167171,"median":-0.833563,"eighty":-0.589629,"marketCap":18143645}],"updateTime":1787467943537},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NCEL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188974254","title":"NewcelX任命世界知名糖尿病治療先驅Camillo Ricordi博士加入科學顧問委員會","url":"https://stock-news.laohu8.com/highlight/detail?id=1188974254","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188974254?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 21:22","pubTimestamp":1783516979,"startTime":"0","endTime":"0","summary":"NewcelX Ltd.宣布,已正式聘请国际知名糖尿病治疗领域先驱Camillo Ricordi博士加入其科学顾问委员会。这一重要人事任命标志着公司在糖尿病创新疗法研发方面迈出了关键一步。\nRicordi博士在胰岛移植和免疫耐受研究领域享有崇高声誉,其开创性工作为糖尿病治疗带来了革命性前景。他的加入预计将为NewcelX的科学战略方向提供权威指导,并加速相关治疗方案的临床转化进程。\n公司表示,此次引进顶尖学术人才,旨在强化研发管线的科学基础,并进一步提升在细胞治疗领域的核心竞争力。业界观察人士认为,该举措可能对NewcelX未来在代谢疾病治疗市场的布局产生深远影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121312334","title":"Newcelx宣佈FDA臨床前會議成功,為Ncel-101啓動1型糖尿病臨床試驗鋪平道路","url":"https://stock-news.laohu8.com/highlight/detail?id=1121312334","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121312334?lang=zh_tw&edition=fundamental","pubTime":"2026-07-01 21:35","pubTimestamp":1782912913,"startTime":"0","endTime":"0","summary":"Newcelx宣布,其与FDA就Ncel-101项目举行的临床前会议取得圆满成功,为推进该疗法针对1型糖尿病的临床试验明确了清晰的路径。此次会议成果标志着公司在该创新疗法的开发进程中迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NCEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191094520","title":"NewcelX公布2025財年業績 攜手Eledon製藥加速推進2026年1型糖尿病療法研發進程","url":"https://stock-news.laohu8.com/highlight/detail?id=1191094520","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191094520?lang=zh_tw&edition=fundamental","pubTime":"2026-04-30 20:17","pubTimestamp":1777551441,"startTime":"0","endTime":"0","summary":"生物技术公司NewcelX Ltd. 近日正式披露2025年度财务报告,同时向投资者同步了与Eledon Pharmaceuticals, Inc. 合作研发1型糖尿病治疗方案的重大进展。据悉,双方将于2026年全面加速该创新疗法的临床开发进程,标志着代谢疾病治疗领域或将迎来突破性技术迭代。若临床进展符合预期,该联合疗法或将成为全球首款通过免疫调控机制逆转1型糖尿病病理进程的生物制剂,潜在市场空间可观。随着研发进程的加速,NewcelX与Eledon制药的技术协同效应将持续释放价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","ELDN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174997049","title":"Newcelx更新企業演示文稿,重點展示與Eledon製藥戰略合作後的1型糖尿病旗艦項目,瑞士生物技術會議前揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=1174997049","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174997049?lang=zh_tw&edition=fundamental","pubTime":"2026-04-20 19:37","pubTimestamp":1776685035,"startTime":"0","endTime":"0","summary":"Newcelx已更新其企业演示文稿,着重强调与Eledon制药达成战略合作后的1型糖尿病旗舰项目。这一更新恰逢瑞士生物技术会议召开前夕,凸显了公司对该项目的重视与推进决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NCEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NCEL\",params:#limit:6,delay:false,,,undefined,":[]}}